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ABSTRACT
Objectives: To review systematically the literature on
patients’ experiences of, and participation in,
technology-based monitoring of mental health
symptoms. This practice was defined as patients
monitoring their mental health symptoms, emotions or
behaviours outside of routine clinical appointments by
submitting symptom data using technology, with
feedback arising from the data (for example, supportive
messages or symptom summaries, being sent to the
patient, clinician or carer).
Design: Systematic review following PRISMA
guidelines of studies evaluating technology-based
symptom monitoring. Tools from narrative synthesis
were used to analyse quantitative findings on
participation rates and qualitative findings on patient
views.
Data sources: PubMed, EMBASE, PsycINFO, BNI,
CINAHL, Cochrane Registers and Web of Science
electronic databases were searched using a
combination of ‘psychiatry’, ‘symptom monitoring’ and
‘technology’ descriptors. A secondary hand search was
performed in grey literature and references.
Results: 57 papers representing 42 studies met the
inclusion criteria for the review. Technology-based
symptom monitoring was used for a range of mental
health conditions, either independently of a specific
therapeutic intervention or as an integrated component
of therapeutic interventions. The majority of studies
reported moderate-to-strong rates of participation,
though a third reported lower rates. Qualitative
feedback suggests that acceptability of monitoring is
related to perceived validity, ease of practice,
convenient technology, appropriate frequency and
helpfulness of feedback, as well as the impact of
monitoring on participants’ ability to manage health
and personal relationships.
Conclusions: Such symptom monitoring practices
appear to be well accepted and may be a feasible
complement to clinical practice. However, there is
limited availability of data and heterogeneity of studies.
Future research should examine robustly patients’ role
in the development and evaluation of technology-based
symptom monitoring in order to maximise its clinical
utility.
BACKGROUND
Symptom monitoring involves patients assess-
ing and documenting changes in their feel-
ings and behaviours outside of clinical
appointments. This can provide mental
health professionals with additional informa-
tion to inform treatment, which may other-
wise not be collected due to time constraints
during routine psychiatric appointments.1 2
Pen and paper symptom monitoring is well
established in psychiatric treatment and
research.3 4 For example, in cognitive–behav-
ioural therapy (CBT), patients ‘self-monitor’,
that is, systematically record dysfunctional
thoughts and associated maladaptive emo-
tions and behaviours, enabling therapists to
track progress.3 In research, a method
known as ecological momentary assessment5
is used to capture the ‘ebb-and-ﬂow’ of psy-
chiatric symptomatology, as participants
record real-time symptoms and context
prompted by digital wristwatches.4 6
Increasingly, symptom monitoring is facili-
tated by technology such as short message
service (SMS), websites and mobile devices7
Strengths and limitations of this study
▪ Can inform design and implementation of
technology-based symptom monitoring, so its
usefulness in clinical practice can be maximised.
▪ Is novel in synthesising quantitative and qualita-
tive data and provides detail on rates of participa-
tion and patient perspectives on usefulness.
▪ Limited availability of data and heterogeneity of
studies allow only for tentative conclusions.
▪ May be conceptually limited as extant research
has rarely gathered patient perspectives and find-
ings are from a small number of studies.
▪ Further, since a broad definition of mental health
is used, this limits the comparison across
studies.
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which, compared with pen and paper, offer various
advantages. First, completion rates may increase due to
in-built reminders and greater ease of use.7 Second, the
information collected may be more accurate and eco-
logically valid than diary data, which is often inaccurate
and incomplete.8 Third, information can be accessed in
real time, increasing the possibility for earlier and more
immediate intervention outside of clinical encounters.2
This is achieved through the generation of feedback
such as supportive messages or symptom summaries sent
to patients, carers and clinicians. Consequently, patients
can access personalised support when needed and clini-
cians can access accurate personalised information to
inform and optimise treatment decisions9 and promote
collaborative care.10 Technology-based symptom moni-
toring incorporating feedback (eg, supportive messages
or symptom summaries) therefore has the potential to
signiﬁcantly inﬂuence routine patient treatment outside
of clinical appointments, when the patient is in their
own environment. Yet, at present, technology-based
symptom monitoring is restricted mainly to the context
of research, to identify patterns and mechanisms of psy-
chopathology, and symptom monitoring data are not fed
back to patients or clinicians in order to inform patient
treatment.4 9 11 However, there are potential limitations
given that other technology-based, self-directed interven-
tions such as computerised CBT, psychoeducation and
skills training websites have high drop out and poor
adherence.12–14 This is associated with factors such as
lack of interactive features and prompting, limited access
and technological literacy, failure to provide human
support, monitoring, or follow-up, and chronicity or
condition severity.12–14
A limitation of the current evidence is that we know
relatively little about how patients experience, engage with
and appraise technology-based symptom monitoring-
speciﬁcally, when employed independently, outside of clin-
ical appointments, to generate feedback for the patient,
their clinician or their carer. It is critical to establish
patients’ perspectives in order to improve our understand-
ing of how to design and implement technology-based
symptom monitoring, and therefore maximise its clinical
utility in community care. Accordingly, the research ques-
tions of this review were as follows:
1. What are the rates of participation in technology-
based symptom monitoring, whereby patients report
symptoms outside of routine clinical appointments,
generating feedback for the patient, clinician or
carer?
2. What are patients’ experiences of using such
monitoring?
METHODS
In July 2015, a systematic search of the electronic data-
bases and grey literature was conducted following
PRISMA guidelines15 and according to a protocol
(available from authors on request). Search terms
combined mental health, symptom monitoring and
technology descriptors and are listed in online supple-
mentary ﬁle 1.
Search strategy
The databases used were: PubMed, EMBASE, PsycINFO,
BNI, CINAHL, Cochrane Registers and Web of Science.
Databases were searched from their inception to July
2015 with no language restrictions. Publication bias was
minimised by including conference papers and grey lit-
erature, with sources including Health Technology
Assessment agencies identiﬁed by the Canadian Agency
for Technology,16 Beacon website, a technology-based
mental health intervention database,17 British Library
Catalogue, Copac theses, Zetoc conferences, OpenGrey
and UK Clinical Research Network Study Portfolio.
Backward citation, that is, reference screening from
included studies; and forward citation, that is, ﬁnding
citations to included studies using Google Scholar, were
also used.
Titles were inspected to remove duplicates and irrele-
vant papers. Abstracts were then screened for a detailed
evaluation. Full texts were checked if there was insufﬁ-
cient information in the abstract. A second independent
researcher (EG) screened a random selection of 20% of
abstracts to ensure the accuracy of screening.
Selection criteria
The population of interest was deﬁned inclusively as par-
ticipants diagnosed with or experiencing subthreshold
symptoms of Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) axis 1 mental
health conditions including adjustment disorders,
anxiety disorders, eating disorders, mood disorders, and
schizophrenia and other psychotic disorders. The inter-
vention was deﬁned as a technological tool used by
patients to monitor subjectively symptoms, emotions or
behaviours outside routine clinical appointments, pro-
viding feedback to the patient, clinician or another party
(such as a carer). This provision of feedback helped to
distinguish relevant studies from those not employing
symptom monitoring as part of treatment. Symptom mon-
itoring in clinical appointments and objective symptom
monitoring (eg, physical movement) were excluded as
the review focused on patients’ involvement in independ-
ently and subjectively reporting symptoms. There was no
restriction on study type; however, papers were required
to report on patient participation rates or experiences.
All included texts were examined independently by a
second reviewer (EG) to conﬁrm inclusion.
Data extraction
Data from each study, including participant demograph-
ics, symptom monitoring characteristics and patient
experience measures, were extracted into a spreadsheet.
The full list of extracted data is listed in online supple-
mentary ﬁle 1. A second reviewer (EG) extracted data
from 20% of the included papers to ensure accuracy.
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One German paper was extracted by a native speaker.18
In four instances, authors provided clariﬁcation via
email.19–22
Analysis
Tools from narrative synthesis were used including vote
counting, tabulation and transforming data into a
common rubric.23 Vote counting was used to provide
initial descriptions of monitoring practices. Tabulation
was used to present quartiles of participation rates, which
were calculated by dividing actual monitoring instances
by the potential number, expressed as a percentage.
Where studies only reported participation rates for
completers, drop outs were assumed to have completed
none of the potential monitoring, resulting in conserva-
tive estimates for these studies. Transforming data into a
common rubric of qualitative codes was used for the
quantitative data on participants’ experiences of symptom
monitoring in order to complete thematic synthesis,24 in
which codes were assigned in an inductive manner and
reﬁned iteratively to identify the main themes.
RESULTS
The search returned 11 529 records, leaving 456 after
the removal of duplicates and irrelevant titles (see ﬁgure 1).
A further 249 were excluded after abstracts was screened
because they did not meet the criteria for symptom
monitoring (n=134), were review papers (n=69),
included a non-mental health population (n=37) or
concerned an unrelated to topic (n=9). The full texts
of all remaining 207 papers were examined, 57 of
which were included. The 57 papers represent 42
unique studies as four studies were reported in multiple
papers. For example, mobile-type25 26 and self-
management support for bulimia nervosa were reported
twice,27 28 while the ChronoRecord pilot was reported in
four papers21 29–31 and its ongoing international study was
reported in 11 papers.32–42
Overview of studies and symptom monitoring protocols
Online supplementary ﬁle 2 summarises the character-
istics of included studies. Papers were published between
1999 and 2015, in English, except one German paper.18
Most papers were from Europe1 18 20 22 27 28 43–57 or
Figure 1 PRISMA diagram. MH, mental health.
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the USA,9 21 29 31 30 58–71 with the rest from
Australia,19 25 26 72 73 Japan74 and one international
study reported in multiple papers.32–42
Most studies were designed to assess feasibility and
were single-arm pilot studies,9 18 27 28 43 47 49 51 52
54–62 66 67 69 70–74 or observational studies.21 29–31 64 68
Some were randomised controlled trials
(RCTs)19 20 22 25 26 44 45 50 59 63 65 and some were non-
randomised trials46 53 that reported the efﬁcacy of
technology-based symptom monitoring in terms of
reduced severity of symptoms,19 22 25 26 remission rates44
or increased adherence compared with paper monitor-
ing.65 In other studies, monitoring was a component of
an intervention, which when evaluated, reported positive
impact on symptoms,20 45 59 63 mixed ﬁndings46 53 or
non-signiﬁcant ﬁndings.50 Five papers contained <10
participants,52 58 64 67 74 21 papers contained <50
participants,9 18 22 43 46–49 53–57 60 65 66 69–73 16 papers
contained between 50 and 99 participants,1 20 21 25 26 29–31
44 45 50 51 59 61–63 and ﬁve papers contained 100 or more
participants,19 27 28 68 one of which was the longitudinal
ongoing study of ChronoRecord.32–42
Technology-based symptom monitoring was used in a
variety of ways in patients with depression,19 22 25 26 47
53 58 63 68 73 74 anxiety,67 bipolar disorders,1 9 21 29–42
48 54 59 60 65 eating disorders18 20 27 28 43–46 49–51 55–70 and
severe mental illness,69 including schizophrenia.57 62 64 In
a few studies, no single diagnosis was targeted.52 61 66 71 72
Such monitoring was often an integrated component of a
particular therapeutic intervention, such as CBT,58 64 67 70
psychoeducation,54 59 60 behavioural activation58 or as
part of an e-therapy.19 20 27 28 43 45 46 49–51 53 55 63 66 72
Monitoring was also used as a stand-alone intervention to
support ongoing treatment,1 9 21 22 25 26 29–42
47 48 52 61 62 65 68 73 74 or as a speciﬁc element of treat-
ment, such as preventing relapse and hospitalisation,57 69
or following discharge.18 44 56 71
Commonly available technologies such as
email,1 48 54 65 SMS,1 18 44 48 52 56 57 62 70 71 or web-
sites19 20 27 28 43 45–47 49–51 53 55 59 63 72 73 74 were typically
used for reporting, though purpose-built software was
also used.9 21 22 25 26 29–42 58 60 61 64 66–69 Participants
either reported only their symptoms,1 18 20 27 43 44 46–54
56 57 63 67 69–71 73 74 or symptoms and other relevant
factors.9 19 21 22 25 26 29–42 45 46 55 58–62 64–66 68 72 The
intensity of monitoring varied; patients typically reported
symptoms retrospectively with respect to the preceding
day,19 44–47 52 54 61 62 65 69 70 74 few days66 68 71 72 or
week.1 18 20 27 28 43 48–51 53 55 56 57 63 73 Other studies
were more intensive and collected multiple momentary
(current) symptom reports per day.9 22 25 26 58–60 64 66 67
Patients were usually prompted to report at a ﬁxed
time,1 9 18 43 44 48–51 54 56 57 61 62 65–68 71 74 though
random prompts were used.22 25 26 58 59 60 64 In
other studies, participants were not prompted,21 29–42 47
53 63 69 70 73 or prompting was optional or
unclear.19 20 27 28 45 46 52 55 72
Participants were usually supported in monitoring as
their clinician received automated feedback generated
by algorithms detecting symptom improvement or
deterioration, warranting follow-up. Such feedback was
in the form of messages,43 49–51 53 57 63 68 69 71 74 graphs
representing symptoms over time1 25–28 45 46 48 54 57
58 63 64 67 73 74 or brief reports.20 43 53 55 61 68 69 In some
studies, patients received the same feedback as clinicians,
as graphs25–28 45 46 48 54 57 58 63 or messages.49–51 68 71 74
In other studies, patients received different content than
clinicians, such as a supportive statement or reminder of
treatment strategy.43 53 69 In some studies, only patients
received feedback, either where symptom monitoring was
used as part of a speciﬁc guided treatment,9 22 52 59 60 66 70
as part of an entirely unguided treatment aimed to
support symptom awareness and self-management,18 21
29–42 44 47 62 65 or as part of a self-guided website.19 72
Rates of participation in technology-based symptom
monitoring
Thirty-three studies provided sufﬁcient detail for partici-
pation rates to be calculated and are presented in table 1,
by quartile. The remaining studies did not provide this
detail.18 27 28 32–42 44 46 48 51 56 73
In the majority of studies, participation rates were in
the upper range,22 45 49 52 53 59 61 62 64 67–70 with many
studies reporting high rates.1 9 21 25 43 54 57 60 71 74
Approximately a third of studies reported lower rates of
participation.19 20 47 50 55 58 63 65 72 When participant
diagnosis and characteristics of the monitoring were
considered, few patterns emerge regarding what may
affect participation rates, most likely due to the variance
in study characteristics. However, participation rates
appear more varied and slightly lower in common
mental health conditions such as anxiety and depress-
ion,19 47 58 63 72 in unguided interventions,19 47 65 72 and
in e-therapy.19 20 50 55 58 63 72 Yet, such factors are not
evenly represented across studies and ﬁndings are
inconclusive.
Patients’ perspectives on technology-based symptom
monitoring
Less than half of the studies collected data on patients’
experiences of technology-based symptom monitoring.
Most studies used closed-response question-
naires9 18 21 22 27 46 47 49 51 53 56 58–62 70 71 73 with some
using open-ended questionnaires,9 47 53 56 semistruc-
tured interviews48 60 73 and focus groups.47 73
The overarching themes were ‘acceptability’ and
‘inﬂuence’ of monitoring, as presented in online supple-
mentary ﬁle 3.
Acceptability of symptom monitoring
This refers to how satisﬁed participants were with aspects
of the monitoring such as technology type, frequency
and duration, and feedback.
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General acceptability of symptom monitoring
Many studies reported moderate-to-strong acceptability
in terms of perceived usefulness and satisfac-
tion.9 27 46 53 58 62 70 73 Participants felt that monitoring
was supportive, made them feel less alone, and that they
would recommend or repeat it.18 However, reminders53
and ﬁxed schedules9 became repetitive or irritating.
Additionally, some participants with affective disorders
reported that assessments did not always capture what
patients wanted to report,9 47 48 59 for example, some-
thing was ‘missing’.47 In other cases, participants with
eating disorders liked the notion of symptom monitoring,
but in practice did not ﬁnd it helpful49 51 and would not
want to repeat it or recommend it to a friend.56
Ease of use
Participants found symptom monitoring easy as it required
little effort and was simple to remember and under-
stand.9 46–48 56 For example, ‘I like the fact that you can
get it done in 40 seconds, it’s nothing at all, it’s very easy
and good’.48 However, it was reported that losing instruc-
tions made the intervention difﬁcult to complete.56
Technology
Participants found various types of technology accept-
able including software, SMS, email and home
telehealth devices.21 48 59–61 However, SMS was criticised
for restricting participants’ ability to report nuanced
experiences: ‘Text is a constricted method of communi-
cation; [it] would have been good to have a website you
could go to, email would be better—less restricted,
more personal…’.56 Participants reported concern over
carrying additional devices.9 60 Some technological difﬁ-
culties were reported, such as failure of devices to save
responses or beep loudly enough,9 or receiving incorrect
or repeat messages in response to symptom reporting.56
Additionally, computer literacy was an issue for partici-
pants who found it difﬁcult and time-consuming to log
in and access monitoring.53
Frequency and duration
There were differing views on the appropriate frequency
of monitoring. Some participants were satisﬁed with
weekly reporting,18 48 56 while others suggested weekly
frequency was insufﬁcient and should be increased to
improve insight into symptoms.49 There were also mixed
views on daily reporting, that is, whether reporting was
not frequent enough,9 or too frequent.47
Helpfulness of feedback
Feedback from technology-based symptom monitoring
was reported to be useful.27 53 60 71 More speciﬁcally,
Table 1 Participation rates by quartile by diagnosis and characteristics of the technology-based symptom monitoring
Low
(0–25%)
Lower middle
(26–50%)
Upper middle
(51–75%)
High
(76–100%)
Diagnosis
Anxiety 67
Depression 19, 47, 58 63 22, 68 25, 74
Anxiety/depression 72 52 53
Bipolar disorder 65 59 1 9 21 54 60
Eating disorder 20, 50, 55 45, 49, 70 43
Mixed 61, 66 71
Schizophrenia 62, 64 57
Severe mental illness 69
Monitoring schedule
Multiple times per day 58 22, 59, 64, 67 9, 25, 60
Daily 19, 47, 65 45, 52, 61, 62, 69 21, 54, 74
Multiple times per week 72 66, 68 71
Weekly 20, 50, 55, 63 49, 53, 70 1, 43, 57
Prompting
Random prompted 58 22, 59, 64 25, 60
Fixed prompted 50, 65 49, 53, 61, 62, 66, 67, 68 1, 9, 43, 54, 57, 71, 74
Unprompted 47, 63 69, 70 21
Optional or unclear if prompted 72 19, 20, 55 45, 52
Guided
Guided 20, 50, 55, 58, 63 22, 45, 49, 52, 53, 59, 61, 64,
67, 68, 69, 70
1, 9, 25, 43, 54, 57, 60,
71, 74
Unguided 72 19, 47, 65 62 21
Context: independent or integrated into intervention
Independent of a specific
therapeutic intervention
47, 65 22, 61, 62, 68, 69 1, 9, 21, 25 57, 60, 71,
74
Integrated component of
face-to-face therapy
52, 59, 64, 67, 70 54
Integrated component of e-therapy 72 19, 20, 50, 55, 58, 63 45, 49, 53 43
Walsh S, et al. BMJ Open 2016;6:e008362. doi:10.1136/bmjopen-2015-008362 5
Open Access
access to graphs representing patients’ mood disorder
symptoms over time were perceived as helpful22 47 48 (or
would have been if the clinician shared them73) with
one participant commenting that ‘It really helps to see a
picture; it really brings it to life… I was quite surprised
by the changes’.47 In one eating disorder study, graphs
were not perceived as helpful but no explanation was
given.46 Studies in which participants received auto-
mated feedback messages varied in their acceptability
from positive overall60 71 to a range of differing
views.18 49 53 56 For example, some participants with
eating disorders found texts encouraging, while others
found them patronising.56 In two other eating disorder
studies, half of participants,49 or almost all,51 did not
think feedback messages were appropriate. This was
echoed in participants with depression and anxiety,
some of whom felt that feedback messages were repeti-
tive and impersonal.53
Influence of symptom monitoring
This refers to the inﬂuence of monitoring on insight
and health management, and relationships with others.
Insight into health and management
Participants with mood disorders reported an improved
understanding of their condition and perceived them-
selves as better able to cope with it, or better able to play
an active role in their treatment, following symptom
monitoring.9 48 53 60 61 73 However, participants felt this
could be further improved by allowing different symp-
toms to be monitored at different times, depending on
mania or depression;48 or allowing the monitoring of
other factors, such as stress levels and alcohol intake, to
improve their understanding of the impact of these
factors on symptoms.9 It was also suggested that monitor-
ing practices should differ depending on the stage of
illness, such as whether one is new to treatment or re-
covering from an episode of mania or depression.9
Similarly, in depression, participants mentioned symptom
monitoring may be more appropriate for new patients
who are less aware of mood ﬂuctuations,47 yet some rela-
tively young patients felt they already knew their symp-
toms.73 However, the opportunity for improved insight
and health management was limited in two studies of
eating disorders, where automated feedback was evalu-
ated as poor.49 56
Relationships with others
Participants felt that symptom monitoring could posi-
tively impact on relationships. In studies of mood disor-
ders, such monitoring was perceived to improve
participants’ interactions with clinicians9 48 and foster
carers’ awareness of the condition.48 However, where
participants could nominate a friend or family to receive
feedback, participants reported that there were issues
with placing burden on that person, and participants
sometimes experienced guilt as a consequence of this.47
However, where monitoring for bulimia was either
completely unguided18 or accompanied by brief postal
feedback,56 this lack of personal support was perceived
negatively, particularly by recently discharged inpatients.
In outpatients, views were more mixed, as some partici-
pants were happy to express their feelings without dis-
cussing with a stranger, while others felt unsupported
and would have preferred to have received personal
contact from a therapist to support them.56
DISCUSSION
Main findings
Despite limited availability of data and heterogeneity of
studies, there is some evidence that technology-based
symptom monitoring is relatively well accepted, given
the moderate-to-strong rates of participation, and overall
positive reports of experience. Lower rates of participa-
tion were found in one-third of studies, but it was not
possible to ﬁrmly establish what contributes to this.
Diagnosis may play a part as the participant experience
data suggest that patients with eating disorders liked
monitoring in theory but not in practice; people with
depression and anxiety had lower rates of participation
and believed technology-based symptom monitoring in
its current forms had limited utility; and people with
bipolar disorder viewed such monitoring more favour-
ably. Lack of prompting and guidance may also contrib-
ute; where participants were unguided, they reported
that feedback messages were unhelpful and perceived
the lack of support negatively. Implementation of
technology-based symptom monitoring as part of an
e-therapy may also be associated with lower participation
rates; however, the experience ﬁndings on such interven-
tions were limited.
Strengths and limitations
This main strength of this review was its systematic
approach in collating the published literature to date
on technology-based symptom monitoring practices,
employing rigorous methodology with a wide search
strategy. A further strength is that the review did not
limit by diagnosis, which allowed papers that were not
diagnosis-speciﬁc to be included.52 53 61 66 69 71 72 This
approach also allowed for more general conclusions on
design principles of mental health symptom monitoring,
which may apply across diagnoses. It also reﬂects the
reality of community mental healthcare practice where
patients can have multiple diagnoses. Still, this approach
has limitations. First, although it may be useful to
compare across diagnoses, the heterogeneity of studies
found makes it difﬁcult to draw ﬁrm conclusions from
the review. The results are narrative, rather than a
meta-analysis, which was not possible due to variable
quality of data among the heterogeneous studies.
Further, this review does not formally appraise the
quality of the studies, as doing so remains contentious in
the context of descriptive accounts.75 As the evidence
base becomes more established and the number of
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RCTs increases, it will be important to assess the quality
of the studies to determine effectiveness. Although
efforts were made to ﬁnd grey literature, the search strat-
egy may still have been biased towards published
research. The second major limitation pertains to the
limited availability of data on participation rates and
patients’ experiences of such monitoring, which renders
it difﬁcult to state ﬁndings conclusively. For example, in
some studies, the average participation rates could not
be derived. Further, the paucity of data on longitudinal
engagement with monitoring makes it difﬁcult to estab-
lish whether participants initially engage well but after a
time drop out,63 or to establish the optimal length of
monitoring. As only half of the included studies sought
participants’ views on monitoring, the resulting data are
limited, especially since very brief, forced-choice ques-
tionnaires were used. As a consequence, the themes
relating to acceptability emerged mainly from just ﬁve
studies collecting open-ended responses or in-depth
interview data, and this sample may therefore be unrep-
resentative. Despite these limitations, the review is a
useful collation of studies that demonstrates the poten-
tial feasibility of technology-based symptom monitoring
outside of appointments to inform treatment, with a
range of patient groups and intervention types. The ten-
tative conclusions may also guide future research.
Comparison with literature
The current review supports previous reports that
patients engage well with technology-based symptom
monitoring,4 76 while introducing a focus on routine
patient treatment rather than monitoring solely for
research purposes. In particular, it supports ﬁndings
indicating that participation rates are moderate-to-strong
in a range of diagnostic groups, including those with
schizophrenia,4 76 which may be surprising given well-
documented rates of treatment non-adherence in this
group.77 The review also suggests a greater variation in
participation for common mental health conditions,
which may relate to patients with depression having
impairments in focus, energy and motivation that affect
willingness to engage in treatment,78 particularly
technology-based interventions.12 It supports previous
research suggesting that participation in guided
technology-based interventions is superior to unguided
ones.79 The review also provides some evidence that
when monitoring is implemented as part of an
e-therapy, there are lower rates of participation, as has
been documented previously.12–14 However, these ﬁnd-
ings must be interpreted with caution due to sampling
biases; there were fewer studies on severe mental illness,
unguided monitoring and e-therapies. Further research
is needed to clarify the impact of patient diagnosis and
characteristics of monitoring on participation.
The ﬁndings from patients’ experiences of monitoring
support the existing literature, which suggests improved
patient understanding of their illness and promotion of
collaborative care;2 10 however, it was noted that the
impact on understanding is dependent on ability to
monitor the most relevant factors, at the most important
times, for example, stage of illness. It is interesting that
the majority of studies in this review asked for retrospect-
ive reports rather than momentary reports, which have
previously been considered to be superior in providing
valid data more readily for timely intervention.76 Given
that the few momentary studies demonstrated good rates
of participation, future research should perhaps investi-
gate this method to capture accurately the ﬂow of
patient experience. The ﬁndings also suggest that perso-
nalised feedback should be used cautiously, as some
found it patronising. One possible option for overcom-
ing this is to involve patients in generating feedback
messages, so that they receive something personal and
meaningful.62 Future research should consider the role
of patients in designing mental health interventions, as
this can improve the acceptability of interventions.80 81
Implications for research and practice
Technology-based symptom monitoring may be a useful
complement to current clinical practices, given the
moderate-to-strong rates of participation and acceptabil-
ity, and potential to improve insight and health manage-
ment, and personal relationships. However, these
ﬁndings are tentative and a number of practical factors
need to be considered when designing future monitor-
ing practices for robust evaluation. To increase the likeli-
hood of good participation, monitoring must capture
what patients want to report, be easy to complete
without requiring high levels of computer literacy and
use the most appropriate technology to capture the
complexity of symptoms. The frequency of interventions
must be carefully considered to create a balance
between generating insightful data on symptoms and
overburdening participants. Feedback arising from mon-
itoring seems to be important for successful implemen-
tation, with objective representations, such as graphs,
potentially more acceptable to patients than automated
messages that fall short of personalisation. Future studies
should consider how to facilitate personalisation,
perhaps by involving patients in generating messages. To
facilitate improvements in insight into health and man-
agement of conditions, ﬂexibility is important, such that
participants are allowed to monitor symptoms that are
most relevant to them at particular phases of their
illness. Careful consideration should be given to
whether, for some conditions, monitoring is perhaps
only useful in early phases of illness. Symptom monitor-
ing is likely to be more acceptable when part of a
guided intervention in which a clinician or other party is
included, in order to facilitate collaboration; however, if
family and friends are included, issues surrounding bur-
dening and guilt should be considered. Future research
may consider ethical aspects, which have rarely been
mentioned in the included studies. Potential problems
include data security and privacy when sensitive informa-
tion is shared via technology82 and expectations that
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symptom reports are being checked around the clock.60
Nevertheless, it is held that such concerns should not
limit progress in the ﬁeld.83 Finally, given that there are
potentially large costs in programming and developing
such interventions, these must be balanced with the
potential savings; cost-effectiveness needs to be estab-
lished, both in feasibility studies and larger trials.82
CONCLUSIONS
The current review has identiﬁed encouraging evidence
of acceptability of a range of technology-based symptom
monitoring practices in routine management of mental
health. Further, it highlights that a number of issues
must be considered when implementing such monitor-
ing. However, the limited quality and availability of data
and heterogeneity of studies mean only tentative conclu-
sions can be drawn. Future research into technology-
based symptom monitoring should robustly examine
patients’ role in the development and evaluation of
monitoring, to further understanding of this area and to
ensure that it can be employed to good clinical effect.
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